Millennium Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$224K Sell
4,067
-39,538
-91% -$2.14M ﹤0.01% 5133
2025
Q4
$2.14M Sell
43,605
-21,385
-33% -$997K ﹤0.01% 3876
2025
Q3
$2.8M Sell
64,990
-13,437
-17% -$525K ﹤0.01% 3729
2025
Q2
$3.01M Buy
78,427
+49,238
+169% +$1.88M ﹤0.01% 3497
2025
Q1
$1.13M Sell
29,189
-62,374
-68% -$2.28M ﹤0.01% 4258
2024
Q4
$3.1M Sell
91,563
-1,367,253
-94% -$49.2M ﹤0.01% 3274
2024
Q3
$59.6M Buy
1,458,816
+1,383,969
+1,849% +$56.6M 0.03% 717
2024
Q2
$2.88M Buy
74,847
+68,595
+1,097% +$2.89M ﹤0.01% 3208
2024
Q1
$268K Sell
6,252
-1,436,678
-100% -$59.2M ﹤0.01% 5204
2023
Q4
$53.5M Sell
1,442,930
-1,181,201
-45% -$42.4M 0.02% 748
2023
Q3
$95.1M Buy
2,624,131
+1,510,679
+136% +$53.6M 0.05% 391
2023
Q2
$39.7M Buy
1,113,452
+62,532
+6% +$2.24M 0.02% 889
2023
Q1
$37.4M Sell
1,050,920
-3,395,085
-76% -$119M 0.02% 878
2022
Q4
$156M Buy
4,446,005
+1,745,848
+65% +$58.2M 0.09% 216
2022
Q3
$79.5M Buy
2,700,157
+1,345,155
+99% +$51M 0.05% 448
2022
Q2
$73.7M Buy
1,355,002
+470,648
+53% +$26M 0.05% 432
2022
Q1
$48.2M Buy
884,354
+77,898
+10% +$4.23M 0.03% 721
2021
Q4
$44.5M Buy
806,456
+334,087
+71% +$17.4M 0.02% 794
2021
Q3
$22.6M Sell
472,369
-217,334
-32% -$10.9M 0.01% 1218
2021
Q2
$34.3M Buy
689,703
+342,880
+99% +$16.5M 0.02% 808
2021
Q1
$15.5M Sell
346,823
-62,187
-15% -$2.82M 0.01% 1330
2020
Q4
$18.8M Sell
409,010
-276,410
-40% -$12.7M 0.01% 1121
2020
Q3
$32.2K Buy
685,420
+254,295
+59% +$12.7M 0.04% 519
2020
Q2
$22M Sell
431,125
-343,115
-44% -$17.6M 0.03% 676
2020
Q1
$36.7M Buy
774,240
+540,210
+231% +$28.8M 0.08% 238
2019
Q4
$13.7M Buy
+234,030
New +$13M 0.02% 1111
2019
Q3
Sell
-154,475
Closed -$7.73M 4318
2019
Q2
$7.73M Sell
154,475
-562,511
-78% -$28.2M 0.01% 1451
2019
Q1
$37.5M Buy
716,986
+424,726
+145% +$21.2M 0.06% 460
2018
Q4
$14M Buy
292,260
+251,213
+612% +$12.4M 0.02% 927
2018
Q3
$2.06M Sell
41,047
-604,690
-94% -$30.7M ﹤0.01% 2413
2018
Q2
$32.5M Buy
645,737
+100,403
+18% +$5.06M 0.04% 611
2018
Q1
$26.6M Sell
545,334
-915,027
-63% -$42.6M 0.04% 726
2017
Q4
$64.7M Buy
1,460,361
+1,054,410
+260% +$48.7M 0.09% 299
2017
Q3
$20.6M Sell
405,951
-1,869,822
-82% -$94.9M 0.03% 780
2017
Q2
$123M Buy
2,275,773
+1,855,666
+442% +$98.9M 0.22% 85
2017
Q1
$22.1M Sell
420,107
-1,181,202
-74% -$59.9M 0.04% 617
2016
Q4
$77.1M Buy
1,601,309
+1,021,508
+176% +$50.5M 0.16% 151
2016
Q3
$31.3M Buy
579,801
+269,347
+87% +$14.8M 0.05% 405
2016
Q2
$16.8M Sell
310,454
-532,743
-63% -$28.1M 0.04% 606
2016
Q1
$42.7M Buy
843,197
+333,071
+65% +$16.6M 0.11% 219
2015
Q4
$25.7M Buy
510,126
+323,247
+173% +$16.5M 0.05% 477
2015
Q3
$8.98M Sell
186,879
-185,508
-50% -$9.66M 0.02% 992
2015
Q2
$19.4M Buy
+372,387
New +$21M 0.04% 643
2015
Q1
Sell
-83,911
Closed -$4.48M 3779
2014
Q4
$4.48M Sell
83,911
-488,208
-85% -$27.3M 0.01% 1460
2014
Q3
$32.9M Buy
572,119
+167,627
+41% +$10.3M 0.08% 286
2014
Q2
$27M Buy
404,492
+129,638
+47% +$8.77M 0.07% 346
2014
Q1
$18.4M Sell
274,854
-1,759
-0.6% -$119K 0.05% 488
2013
Q4
$18.5M Buy
276,613
+40,414
+17% +$2.62M 0.06% 394
2013
Q3
$14.8M Buy
+236,199
New +$15.2M 0.05% 503

Other funds holding GSK

Millennium Management's GSK Position: Q1 2026 in Review

Millennium Management reduced its GSK (GSK) stake by 91% in Q1 2026, selling an estimated $2.14M and leaving 4,067 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #5133.

Millennium Management first reported a position in GSK in Q3 2013 and has held it in 49 quarters since. The position peaked at $156M in Q4 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Millennium Management held 4,067 shares of GSK worth $224K as of Q1 2026.
  • Millennium Management sold 39,538 GSK shares in Q1 2026, an estimated $2.14M.
  • GSK made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5133 holding.
  • Millennium Management first reported a position in GSK in Q3 2013 and has held it in 49 quarters since.
  • Millennium Management's GSK position peaked at $156M in Q4 2022.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.